Arrowstreet Capital’s Arcosa ACA Stock Holding History

Arrowstreet Capital’s Portfolio ACA Stock Details ACA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,415	Closed	-$379K	–	1483
2024 Q1	$379K	Buy	+4,415	New	+$359K	﹤0.01%	1500
2023 Q4	–	Sell	-12,681	Closed	-$912K	–	1382
2023 Q3	$912K	Buy	+12,681	New	+$962K	﹤0.01%	1006
2023 Q2	–	Sell	-22,941	Closed	-$1.45M	–	1194
2023 Q1	$1.45M	Buy	+22,941	New	+$1.35M	﹤0.01%	983
2021 Q1	–	Sell	-3,900	Closed	-$214K	–	2202
2020 Q4	$214K	Buy	+3,900	New	+$199K	﹤0.01%	2177
2020 Q1	–	Sell	-56,435	Closed	-$2.51M	–	1838
2019 Q4	$2.51M	Buy	56,435 +20,031	+55%	+$770K	0.01%	1063
2019 Q3	$1.25M	Buy	+36,404	New	+$1.26M	﹤0.01%	1108
2019 Q2	–	Sell	-31,507	Closed	-$963K	–	1352
2019 Q1	$963K	Buy	31,507 +23,407	+289%	+$715K	﹤0.01%	1330
2018 Q4	$224K	Buy	+8,100	New	+$223K	﹤0.01%	1234

Other funds holding ACA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Arrowstreet Capital's ACA Position: Q2 2024 in Review

Arrowstreet Capital sold out of Arcosa (ACA) in Q2 2024, closing a stake of 4,415 shares — an estimated $379K sold.

Arrowstreet Capital first reported a position in ACA in Q4 2018 and held it in 8 quarters. The position peaked at $2.51M in Q4 2019. 329 funds tracked by Wall St. Rank hold ACA as of Q2 2024.

Arrowstreet Capital reported no remaining Arcosa position as of Q2 2024 after selling out during the quarter.
Arrowstreet Capital sold 4,415 Arcosa shares in Q2 2024, an estimated $379K.
Arrowstreet Capital first reported a position in Arcosa in Q4 2018 and held it in 8 quarters.
Arrowstreet Capital's Arcosa position peaked at $2.51M in Q4 2019.
329 funds tracked by Wall St. Rank held Arcosa as of Q2 2024.

Based on Arrowstreet Capital's 13F filing for Q2 2024, filed 14 Aug 2024.